HTGMQ Stock - HTG Molecular Diagnostics, Inc.
Unlock GoAI Insights for HTGMQ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $6.37M | $8.91M | $8.55M | $19.20M | $21.50M |
| Gross Profit | $1.79M | $4.81M | $4.56M | $10.29M | $16.41M |
| Gross Margin | 28.2% | 54.0% | 53.3% | 53.6% | 76.3% |
| Operating Income | $-20,829,596 | $-17,823,826 | $-19,585,639 | $-18,960,105 | $-16,159,231 |
| Net Income | $-21,594,476 | $-17,145,170 | $-20,870,218 | $-19,297,664 | $-16,453,918 |
| Net Margin | -339.2% | -192.5% | -244.1% | -100.5% | -76.5% |
| EPS | $-24.28 | $-29.66 | $-54.12 | $-91.17 | $-107.61 |
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Visit WebsiteEarnings History & Surprises
HTGMQEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | — | — | — |
Q4 2024 | Dec 23, 2024 | — | — | — | — |
Q3 2024 | Sep 27, 2024 | $-2.16 | — | — | — |
Q2 2024 | Jun 28, 2024 | $-2.28 | — | — | — |
Q1 2024 | Feb 19, 2024 | $-0.68 | — | — | — |
Q4 2023 | Nov 9, 2023 | $-1.84 | — | — | — |
Q3 2023 | Sep 28, 2023 | $-1.84 | — | — | — |
Q2 2023 | Apr 19, 2023 | $-1.84 | $-4.47 | -143.1% | ✗ MISS |
Q2 2023 | Apr 8, 2023 | $-1.84 | $-2.28 | -24.1% | ✗ MISS |
Q3 2022 | Sep 30, 2022 | $-6.42 | $-4.91 | +23.6% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | $-7.80 | $-6.42 | +17.7% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | $-8.58 | $-9.73 | -13.4% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-8.24 | — | — |
Q3 2021 | Sep 30, 2021 | $-7.08 | $-7.24 | -2.3% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | — | $-4.69 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-9.63 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-9.95 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-13.47 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-15.63 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-15.22 | — | — |
Latest News
Frequently Asked Questions about HTGMQ
What is HTGMQ's current stock price?
What is the analyst price target for HTGMQ?
What sector is HTG Molecular Diagnostics, Inc. in?
What is HTGMQ's market cap?
Does HTGMQ pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HTGMQ for comparison